Patents by Inventor Steve Adler
Steve Adler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11246662Abstract: Various embodiments provide a cardiac mapping and model merging method including: generating a premature ventricular contraction (PVC) activation map of a heart based on a three-dimensional (3D) heart model and PVC electrocardiogram (ECG) data recording during PVC of the heart; generating a 3D internal surface model of the heart by triangulating point-by-point contact data collected during an electrophysiology (EP) procedure; merging the 3D activation map and the 3D internal surface model to form a PVC activation surface model; and pacing the heart at a first pacing location disposed in an area of earliest activation identified in PVC activation surface model.Type: GrantFiled: July 31, 2018Date of Patent: February 15, 2022Assignee: CATHETER PRECISION, INC.Inventor: Steve Adler
-
Patent number: 10932863Abstract: Various embodiments provide a cardiac mapping method including: generating an activation map of a heart based on electrocardiogram (ECG) data of a heart and a three-dimensional (3D) heart model; performing an electrophysiology (EP) procedure to determine a first pacing location; pacing the heart at the first pacing location using an EP catheter; determining whether the pacing at the first pacing location generates a desired cardiac response; displaying guidance information related to a second pacing location on one or both of the activation map and the internal surface map, when the first pacing location is determined not to generate the desired cardiac response; moving the pacing catheter to the second pacing location, based on the guidance information; and pacing the heart at the second pacing location.Type: GrantFiled: July 31, 2018Date of Patent: March 2, 2021Assignee: Catheter Precision, Inc.Inventor: Steve Adler
-
Publication number: 20210001227Abstract: Described herein are computerized methods and systems for enabling remote participation in sporting event decision-making. A current game situation in a sporting event is received by a server from a remote device. The server retrieves plays applicable to the current game situation from a playbook. The server generates a playcall UI comprising the retrieved play categories and plays and transmits the playcall UI to fan computing devices. The server receives a vote for one of the plays from the fan computing devices. The server determines a selected play based on the received votes. The server transmits the selected play to player computing devices associated with players involved in the sporting event, wherein the players execute the selected play. The current game situation is updated at the remote device based upon an outcome of the selected play.Type: ApplicationFiled: September 7, 2020Publication date: January 7, 2021Inventors: Sohrob Farudi, Steve Adler, Raymond Austin, Grant Cohen, Patrick Dees
-
Patent number: 10713790Abstract: Various embodiments provide a cardiac mapping method including: recording premature ventricular contraction (PVC) electrocardiogram (ECG) data during PVC of a heart; generating a PVC activation map of the heart, based on the PVC ECG data and a three-dimensional (3D) heart model generated based on two-dimensional (2D) images of the heart, the PVC activation map including an area of earliest activation; generating a reference image by modifying on one of the 2D images to identify the area of earliest activation; displaying both the PVC activation map and the reference image; and pacing the heart at a first pacing location disposed in the area of earliest activation.Type: GrantFiled: July 31, 2018Date of Patent: July 14, 2020Assignee: CATHETER PRECISION, INC.Inventor: Steve Adler
-
Publication number: 20200030528Abstract: An implantable drug delivery device and method that includes a sensor device for detecting deflection of a diaphragm at a first time from a first position within a diaphragm chamber of an accumulator of the implantable drug delivery device. A cycle count may be incremented in response to the diaphragm returning to the first position within the diaphragm chamber, each time during cyclical deflections within the diaphragm chamber. A flow rate of infusate may be determined based on a volume of the diaphragm chamber, the cycle count, and an elapsed time since the first time. Once the flow rate is determined, a processor may determine whether the flow rate of infusate is normal based on a comparison of the determined flow rate to at least one threshold flow rate.Type: ApplicationFiled: October 4, 2019Publication date: January 30, 2020Inventors: Paul BURKE, Steve ADLER, Robert Lash
-
Publication number: 20200029817Abstract: Various embodiments provide a cardiac imaging system, method, and kit, the system including fiducial markers configured to be placed on a patient and configured to be recognizable using image processing, an external imaging device configured to generate image data of a patient's body including the fiducial markers and electrocardiogram (ECG) leads, and a processing unit configured to identify anatomical locations corresponding to the fiducial markers by detecting light reflected from the fiducial markers included in the image data and use the identified locations to merge the image data with a 3D anatomical model of the patient's chest.Type: ApplicationFiled: July 26, 2019Publication date: January 30, 2020Inventor: Steve ADLER
-
Publication number: 20190043197Abstract: Various embodiments provide a cardiac mapping method including: recording premature ventricular contraction (PVC) electrocardiogram (ECG) data during PVC of a heart; generating a PVC activation map of the heart, based on the PVC ECG data and a three-dimensional (3D) heart model generated based on two-dimensional (2D) images of the heart, the PVC activation map including an area of earliest activation; generating a reference image by modifying on one of the 2D images to identify the area of earliest activation; displaying both the PVC activation map and the reference image; and pacing the heart at a first pacing location disposed in the area of earliest activation.Type: ApplicationFiled: July 31, 2018Publication date: February 7, 2019Inventor: Steve ADLER
-
Publication number: 20190038363Abstract: Various embodiments provide a cardiac mapping method including: generating an activation map of a heart based on electrocardiogram (ECG) data of a heart and a three-dimensional (3D) heart model; performing an electrophysiology (EP) procedure to determine a first pacing location; pacing the heart at the first pacing location using an EP catheter; determining whether the pacing at the first pacing location generates a desired cardiac response; displaying guidance information related to a second pacing location on one or both of the activation map and the internal surface map, when the first pacing location is determined not to generate the desired cardiac response; moving the pacing catheter to the second pacing location, based on the guidance information; and pacing the heart at the second pacing location.Type: ApplicationFiled: July 31, 2018Publication date: February 7, 2019Inventor: Steve ADLER
-
Publication number: 20190038357Abstract: Various embodiments provide a cardiac mapping and model merging method including: generating a premature ventricular contraction (PVC) activation map of a heart based on a three-dimensional (3D) heart model and PVC electrocardiogram (ECG) data recording during PVC of the heart; generating a 3D internal surface model of the heart by triangulating point-by-point contact data collected during an electrophysiology (EP) procedure; merging the 3D activation map and the 3D internal surface model to form a PVC activation surface model; and pacing the heart at a first pacing location disposed in an area of earliest activation identified in PVC activation surface model.Type: ApplicationFiled: July 31, 2018Publication date: February 7, 2019Inventor: Steve Adler
-
Patent number: 10173004Abstract: An “MRI-safe” implantable infusion apparatus and a method that include a flow actuated valve (FAV) that closes to prevent a free flow of an infusate to a patient during an MRI procedure, and a release mechanism that opens the valve so that the apparatus may return to normal operation following the MRI procedure. In this manner, patient safety is improved and an inconvenience of having to empty a pump reservoir before undergoing the MRI procedure may be avoided.Type: GrantFiled: December 20, 2013Date of Patent: January 8, 2019Assignee: Flowonix Medical IncorporatedInventors: Paul Burke, Steve Adler, Benjamin Piecuch, Steve Hantman
-
Publication number: 20180303345Abstract: Various embodiments provide a cardiac imaging system and method that includes using a portable electrocardiogram (ECG) recorder to record ECG data of a patient having an episodic cardiac condition for a time period sufficient for symptoms of the episodic cardiac condition to occur. The recorded ECG data may be provided to a processing unit along with other patient data. The processing unit may generate a three-dimensional (3D) activation map showing the propagation of electrical signals through the patient's heart. Based on the provided patient data, the processing unit may display an ablation point on the 3D activation map, the ablation point being configured to alleviate the episodic cardiac condition.Type: ApplicationFiled: April 18, 2018Publication date: October 25, 2018Inventor: Steve ADLER
-
Patent number: 10010670Abstract: Methods for programming an implantable drug delivery device using a mobile computing device that include establishing a connection with a telemetry unit configured for wireless communication with the implantable drug delivery device, displaying user-selectable drug delivery settings for the implantable drug delivery device, receiving at least one selection of a drug delivery setting, translating the received selection into a signal format readable by the telemetry unit, and sending the translated signal to the telemetry unit to program the implantable drug delivery device. Further embodiments include telemetry units for communication with an implantable drug delivery device, and patient programmers and a method for patient modification to a programmed drug delivery regimen.Type: GrantFiled: June 26, 2017Date of Patent: July 3, 2018Assignee: Flowonix Medical IncorporatedInventors: Paul Burke, Steve Adler
-
Patent number: 9968734Abstract: Methods for programming an implantable drug delivery device using a mobile computing device that include establishing a connection with a telemetry unit configured for wireless communication with the implantable drug delivery device, displaying user-selectable drug delivery settings for the implantable drug delivery device, receiving at least one selection of a drug delivery setting, translating the received selection into a signal format readable by the telemetry unit, and sending the translated signal to the telemetry unit to program the implantable drug delivery device. Further embodiments include telemetry units for communication with an implantable drug delivery device, and patient programmers and a method for patient modification to a programmed drug delivery regimen.Type: GrantFiled: October 3, 2017Date of Patent: May 15, 2018Assignee: Flowonix Medical IncorporatedInventors: Paul Burke, Steve Adler
-
Publication number: 20180021510Abstract: Methods for programming an implantable drug delivery device using a mobile computing device that include establishing a connection with a telemetry unit configured for wireless communication with the implantable drug delivery device, displaying user-selectable drug delivery settings for the implantable drug delivery device, receiving at least one selection of a drug delivery setting, translating the received selection into a signal format readable by the telemetry unit, and sending the translated signal to the telemetry unit to program the implantable drug delivery device. Further embodiments include telemetry units for communication with an implantable drug delivery device, and patient programmers and a method for patient modification to a programmed drug delivery regimen.Type: ApplicationFiled: October 3, 2017Publication date: January 25, 2018Inventors: Paul BURKE, Steve ADLER
-
Publication number: 20180001018Abstract: Methods for programming an implantable drug delivery device using a mobile computing device that include establishing a connection with a telemetry unit configured for wireless communication with the implantable drug delivery device, displaying user-selectable drug delivery settings for the implantable drug delivery device, receiving at least one selection of a drug delivery setting, translating the received selection into a signal format readable by the telemetry unit, and sending the translated signal to the telemetry unit to program the implantable drug delivery device. Further embodiments include telemetry units for communication with an implantable drug delivery device, and patient programmers and a method for patient modification to a programmed drug delivery regimen.Type: ApplicationFiled: June 26, 2017Publication date: January 4, 2018Inventors: Paul BURKE, Steve ADLER
-
Patent number: 9700669Abstract: Methods for programming an implantable drug delivery device using a mobile computing device that include establishing a connection with a telemetry unit configured for wireless communication with the implantable drug delivery device, displaying user-selectable drug delivery settings for the implantable drug delivery device, receiving at least one selection of a drug delivery setting, translating the received selection into a signal format readable by the telemetry unit, and sending the translated signal to the telemetry unit to program the implantable drug delivery device. Further embodiments include telemetry units for communication with an implantable drug delivery device, and patient programmers and a method for patient modification to a programmed drug delivery regimen.Type: GrantFiled: April 14, 2016Date of Patent: July 11, 2017Assignee: FLOWONIX MEDICAL INCORPORATEDInventors: Paul Burke, Steve Adler
-
Publication number: 20160303313Abstract: Methods for programming an implantable drug delivery device using a mobile computing device that include establishing a connection with a telemetry unit configured for wireless communication with the implantable drug delivery device, displaying user-selectable drug delivery settings for the implantable drug delivery device, receiving at least one selection of a drug delivery setting, translating the received selection into a signal format readable by the telemetry unit, and sending the translated signal to the telemetry unit to program the implantable drug delivery device. Further embodiments include telemetry units for communication with an implantable drug delivery device, and patient programmers and a method for patient modification to a programmed drug delivery regimen.Type: ApplicationFiled: April 14, 2016Publication date: October 20, 2016Inventors: Paul BURKE, Steve ADLER
-
Publication number: 20160303318Abstract: An implantable drug delivery device and method that includes a sensor device for detecting the motion of a diaphragm of an accumulator over time. Sensor data from the sensor device may enable indirect measurement of the flow conditions of the device. A processor within the implantable drug delivery device may use the sensor data to detect when motion of the diaphragm of the accumulator over time is outside normal or acceptable parameters and take an action in response.Type: ApplicationFiled: April 14, 2016Publication date: October 20, 2016Inventors: Paul BURKE, Steve ADLER
-
Publication number: 20140228765Abstract: A refillable and implantable infusion apparatus and method that includes a needle penetration detector that detects and indications the position of a needle relative to a septum of a drug reservoir of the implantable infusion apparatus. With the needle position data, medical professionals may better ensure they are injecting drugs into the drug reservoir, thus, improving patient safety.Type: ApplicationFiled: February 4, 2014Publication date: August 14, 2014Applicant: Flowonix Medical IncorporatedInventors: Paul BURKE, Steve ADLER, Robert M. HANSEN
-
Publication number: 20140194851Abstract: An “MRI-safe” implantable infusion apparatus and method that includes a flow actuated valve (FAV) that closes to prevent a free flow of infusate to a patient during an MRI procedure, and a release mechanism that opens the valve so that the device may return to normal operation following the MRI procedure. In this manner, patient safety is improved and the inconvenience of having to empty the pump reservoir before undergoing an MRI procedure may be avoided.Type: ApplicationFiled: December 20, 2013Publication date: July 10, 2014Applicant: Flowonix Medical IncorporatedInventors: Paul BURKE, Steve ADLER, Benjamin PIECUCH, Steve HANTMAN